Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease

British Journal of Haematology

Volumn 135, Issue 4, 2006, Pages 574-582

  Fung, Ellen B ^a   Harmatz, Paul R ^a   Lee, Phillip D K ^b   Milet, Meredith ^a   Bellevue, Rita ^c   Jeng, Michael R ^d   Kalinyak, Karen A ^e   Hudes, Mark ^a   Bhatia, Suruchi ^a   Vichinsky, Elliott P ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

^d STANFORD UNIVERSITY   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Endocrinopathy; Iron overload; Sickle cell disease; Thalassaemia; Transfusion therapy

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CANADA; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOCRINE DISEASE; GROWTH DISORDER; HEMOGLOBINOPATHY; HUMAN; HYPOGONADISM; IRON OVERLOAD; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SICKLE CELL ANEMIA; THALASSEMIA; UNITED KINGDOM; UNITED STATES;

ADULT; ANEMIA, SICKLE CELL; ANTHROPOMETRY; BLOOD TRANSFUSION; DIABETES MELLITUS, TYPE 2; ENDOCRINE SYSTEM DISEASES; FEMALE; GROWTH DISORDERS; HUMANS; HYPOGONADISM; HYPOTHYROIDISM; IRON OVERLOAD; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THALASSEMIA;

EID: 33750049951     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06332.x     Document Type: Article

References (35)

1. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Piga, A., Di Gregorio, F., Gamberini, M.R., Sabato, V., Melevendi, C., Cappellini, M.D. & Verlato, G. (1998) Survival and disease complications in thalassemia major. Annals of the New York Academy of Sciences, 850, 227-231.
2. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M.D., DelVecchio, G.C., Romeo, M.A., Forni, G.L., Gamberni, M.R., Ghilardi, R., Piga, A. & Cnaan, A. (2004) Survival and complications in subjects with thalassemia major treated with transfusion and desferioxamine. Haematologica, 89, 1187-1193.
3. Bronspiegel-Weintrob, N., Olivieri, N.F., Tyler, B., Andrews, D.F., Freedman, M.H. & Holland, F.J. (1990) Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major. The New England Journal of Medicine, 13, 713-719.
4. Caruso-Nicoletti, M., De Sanctis, V., Cavallo, L., Raiola, G., Ruggiero, L., Skordis, N. & Wonke, B. (2001) International workshop on management of puberty for optimum auxological results. Management of puberty for optimal auxological results in beta-thalassemia major. Journal of Pediatric Endocrinology and Metabolism, 14 (Suppl. 2), 939-944.
5. Chan, Y.L., Li, C.K., Pang, L.M. & Chik, K.W. (2000) Desferrioxamine-induced long bone changes in thalasaemic patients-radiographic features, prevalence of and relations with growth. Clinical Radiology, 55, 610-614.
6. Chatterjee, R. & Katz, M. (2000) Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clinical Endocrinology, 53, 33-42.
7. Cunningham, M.J., Macklin, E.A., Neufeld, E.J. & Cohen, A.R. (2004) Thalassemia clinical research network. Complications of beta thalassemia in North America. Blood, 104, 34-39.
8. Fung, E.B., Harmatz, P., Milet, M., Ballas, S.K., DeCastro, L., Hagar, W., Owen, W., Olivieri, N., Smith-Whitley, K., Darbari, D., Wang, W. & Vichinsky, E.P. (2006) Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the Multi-Center Study of Iron Overload. American Journal of Hematology (in press).
9. Harris, M.I., Flegal, K.M., Cowie, C.C., Eberhardt, M.S., Goldstein, D.E., Little, R.R., Wiedmeyer, H.-M. & Byrd-Holt, D.D. (1998) Prevalence of diabetes and impaired fasting glucose in US Adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care, 21, 518-524.
10. Henderson, R.A., Saavedra, J.M. & Dover, G.J. (1994) Prevalence of impaired growth in children with homozygous sickle cell anemia. American Journal of Medical Science, 307, 405-407.
11. Herman-Giddens, M.E., Slora, E.J., Wasserman, R.C., Bourdony, C.J., Bhapkar, M.V., Koch, G.G. & Hasemeier, C.M. (1997) Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics, 99, 505-512.
12. Hollowell, J.G., Staehling, N.W., Flanders, W.D., Hannon, W.H., Gunter, E.W., Spencer, C.A. & Braverman, L.E. (2002) Serum TSH, T4 and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). The Journal of Clinical Endocrinology and Metabolism, 87, 489-499.
13. Italian working group on endocrine complications in non-endocrine diseases. (1995) Multicentre study on prevalence of endocrine complications in thalassemia major. Clinical Endocrinology, 42, 581-586.
14. Jensen, C.E., Tuck, S.M., Old, J., Morris, R.W., Yardumian, A., De Sanctis, V., Hoffbrand, A.V. & Wonke, B. (1997) Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in subjects with beta-thalassemia. European Journal of Haematology, 59, 76-81.
15. Kanaya, A.M., Harris, F., Volpato, S., Perez-Stable, E.J., Harris, T. & Bauer, D.C. (2002) Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Archives of Internal Medicine, 162, 773-779.
16. Kuczmarski, R.J., Ogden, C.L., Grummer-Strawn, L.M., Flegal, K.M., Guo, S.S., Wei, R., Mei, Z., Curtin, L.R., Roche, A.F. & Johnson, C.L. (2000) CDC Growth Charts: United States. Advance Data, 8, 1-27.
17. Ladis, V., Berdousi, E., Palamidou, F., Agrafioti, C., Papadopoulou, A., Anagnostopoulos, G., Theodorides, C. & Kattamis, C. (2000) Morbidity and mortality of iron intoxication in adult subjects with thalassemia major and effectiveness of chelation. Transfusion Science, 23, 255-256.
18. Low, L.C. (1997) Growth, puberty and endocrine function in beta-thalassaemia major. Journal of Pediatric Endocrinology and Metabolism, 10, 175-184.
19. Low, L.C. (2005) Growth of children with beta-thalassemia major. Indian Journal of Pediatrics, 72, 159-164.
20. Morris, N.N. & Udry, J.R. (1980) Validation of self administered instrument to assess stage of adolescent development. Journal of Youth and Adolescence, 9, 271-280.
21. Olivieri, N.F. (2001) Progression of iron overload in sickle cell disease. Seminars in Hematology, 38(Suppl. 1), 57-62.
22. Phebus, C.K., Gloninger, M.F. & Maciak, B.J. (1984) Growth patterns by age and sex in children with sickle cell disease. The Journal of Pediatrics, 105, 28-33.
23. Phillips, G., Becker, B., Keller, V.A. & Hartman, J. (1992) Hypothyoidism in adults with sickle cell anemia. The American Journal of Medicine, 92, 567-570.
24. Pippard, M.J. (1994) Secondary iron overload. In: Iron Metabolism in Health and Disease (eds. J.H. Brock, J.W. Halliday, M.J. Pippard & L.W. Powell ), pp. 272-300. WB Saunders, London.
25. Platt, O.S., Rosenstock, W. & Espeland, M.A. (1984) Influence of sickle hemoglobinopathies on growth and development. The New England Journal of Medicine, 311, 7-12.
26. Porter, J.B. (2001) Practical management of iron overload. British Journal of Haematology, 115, 239-252.
27. Shalitin, S., Carmi, D., Weintrob, N., Phillip, M., Miskin, H., Kornreich, L., Yilber, R., Zaniv, I. & Tamarz, H. (2005) Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. European Journal of Haematology, 74, 93-100.
28. Soliman, A.T., elZalabany, M., Amer, M. & Ansari, B.M. (1999) Growth and pubertal development in transfusion dependent children and adolescents with thalassemia major and sickle cell disease: a comparative study. Journal of Tropical Pediatrics, 45, 23-30.
29. Tanner, J.M. (1962) Growth at Adolescence, 2nd edn. Blackwell Scientific, Oxford.
30. Telfer, P.T., Holden, S., Walker, M., Hoffbrand, A.V. & Wonke, B. (2000) Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. British Journal of Haematology, 110, 971-977.
31. Thalassemia Standards of Care. (2000) Document Prepared in Response to Thalassemia Providers Conference. Pasadena, CA, http://www.thalassemia.com/ SOC_guidelines.html.
32. Tienboon, P., Sangnansermsri, T. & Fuchs, G.J. (1996) Malnutrition and growth abnormalities in children with beta-thalassaemia. Southeast Asian Journal of Tropical Medicine and Public Health, 27, 356-361.
33. Vichinsky, E., Butensky, E., Fung, E., Hudes, M., Theil, E., Ferrell, L., Williams, R., Louie, L., Lee, P.D.K. & Harmatz, P. (2005) Comparison of organ dysfunction in transfused subjects with SCD or β thalassemia. American Journal of Hematology, 80, 70-74.
34. Walter, P.B., Fung, E.B., Killilea, D.W., Jiang, Q., Hudes, M., Madden, J., Porter, J., Evans, P., Vichinsky, E. & Harmatz, P. (2006) Oxidative stress and inflammation in iron-overloaded patients with B-thalassaemia or sickle cell disease. British Journal of Haematology, 135, 254-264.
35. Zemel, B.S., Kawchak, D.A., Fung, E.B., Ohene-Frempong, K. & Stallings, V.A. (2002) Effect of zinc supplementation on growth and body composition in children with sickle cell disease. American Journal of Clinical Nutrition, 75, 300-307.